Literature DB >> 2896211

Prerequisite for the induction of lymphokine-activated killer cells from T lymphocytes.

H Sawada1, T Abo, S Sugawara, K Kumagai.   

Abstract

Human blood mononuclear cells were separated into Leu-11+7-NK, Leu-11-7+, and Leu-11-7-T cells by means of a combination of the Percoll gradient method and C-mediated cytolysis using mAb. When purified Leu-11+7-NK, Leu-11-7+, and Leu-11-7-T cells were cultured with rIL 2 (500 U/ml) for 6 days in a medium supplemented with 10% FCS, Leu-11+7-NK cells responded at the maximum level and Leu-11-7+ cells responded moderately as shown by both cell-proliferation response and cytotoxic activity generated. On the other hand, Leu-11-7-T cells did not respond at all to rIL-2. However, when Leu-11-7-T cells were cultured with rIL-2 in a medium supplemented with 10% autologous serum, they showed considerable responsiveness to rIL-2. In addition, much greater response to Leu-11-7-T cells were produced by the addition of monocytes. Monocyte cytokines, neither IL 1, IFN-gamma, TNF, nor their combination were able to substitute for monocytes in the induction culture. In contrast, the response level of Leu-11+7- NK cells remained unchanged irrespective of supplementation with autologous serum to medium or the addition of monocytes to the culture. These results indicated that culture conditions in the experiments significantly affected the results as to determination of lymphokine-activated killer cell precursors, especially the result pertaining to the conversion of T lymphocytes to lymphokine-activated killer cells. Under appropriate conditions, not only NK cells but also T cells are important precursors of lymphokine-activated killer cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2896211

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Increase in CD57 + CD16-lymphocytes in workers exposed to benzidine and beta-naphthylamine: assessment of natural killer cell subpopulations.

Authors:  T Tanigawa; S Araki; T Abo; S Sakurai
Journal:  Int Arch Occup Environ Health       Date:  1996       Impact factor: 3.015

2.  Partial correction of defective generation of lymphokine-activated killer cells in patients with chronic myelogenous leukaemia after in vivo treatment with interferon-alpha (Wellferon).

Authors:  G Pawelec; E Schneider; G Ehninger; A Rehbein; H Schmidt
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

3.  Evidence that interleukin-4 suppression of lymphokine-activated killer cell induction is mediated through monocytes.

Authors:  B Brooks; H Parry; J Lawry; R Rees
Journal:  Immunology       Date:  1992-02       Impact factor: 7.397

4.  Phenotypic and functional analysis of lymphokine-activated killer (LAK) cell clones. Ability of CD3+, LAK cell clones to produce interferon-gamma and tumor necrosis factor upon stimulation with tumor targets.

Authors:  A S Chong; A Aleksijevic; P Scuderi; E M Hersh; W J Grimes
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

5.  Identification of activated T cell receptor gamma delta lymphocytes in the liver of tumor-bearing hosts.

Authors:  S Seki; T Abo; T Masuda; T Ohteki; A Kanno; K Takeda; H Rikiishi; H Nagura; K Kumagai
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

6.  The inhibitory effect of human interferon alpha on the generation of lymphokine-activated killer activity.

Authors:  Y Tokuda; N Ebina; S H Golub
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

7.  Interleukin-2-induced lymphoproliferative responses.

Authors:  A Winkelstein; L D Weaver; N Salva; L L Machen
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

8.  Effects of tumour necrosis factor-alpha (TNF-alpha), IL-1 beta and monocytes on lymphokine-activated killer (LAK) induction from natural killer (NK) cells and T lymphocytes.

Authors:  K Yoneda; T Osaki; T Yamamoto; E Ueta
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

9.  Induction of lymphokine-activated killer cells with low-dose interleukin 2 and interferon-gamma in oral cancer patients.

Authors:  K Yoneda; T Yamamoto; E Ueta; T Osaki
Journal:  J Clin Immunol       Date:  1992-07       Impact factor: 8.317

10.  MAC technique (morphology antibody chromosomes) in phenotypic identification of proliferating NK and T cells in interleukin-2-stimulated lymphocyte cultures.

Authors:  P E Kovanen; T Timonen; I Seppälä; S Knuutila
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.